Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...

Tribeca Global Natural Resources Ltd. ( ($AU:TGF) ) just unveiled an update. Tribeca Global Natural Resources Ltd. has announced an update ...

The tender offer will expire at 5:00 p.m. ET on Tuesday, November 18, 2025, unless extended or earlier terminated. The full terms, conditions and other details of the tender offer are set forth in the ...

An announcement from Tribeca Global Natural Resources Ltd. ( ($AU:TGF) ) is now available. Tribeca Global Natural Resources Ltd. has announced an ...

Data from Incyte’s TGFβR2×PD-1 Bispecific Antibody and KRAS G12D Inhibitor to be Presented at the ESMO Congress 2025 ...

Agrees to Repurchase of All Shares Held By ADAR1 Capital Management and Pontifax Venture Capital Plans to Commence Tender ...

The US FDA has granted breakthrough therapy designation (BTD) to the bifunctional antibody ficerafusp alfa (BCA101) in ...

Gyre Pharmaceuticals has completed participant enrolment for its 52-week Phase III clinical trial assessing Pirfenidone ...

You have probably seen the striking image — a face dotted with blood, promising radiant, youthful and glowing skin. It’s not ...

These findings demonstrate that OT+A5i has a significant ability to extend health span and highlight the sex-specific ...

A team of scientists has mapped the regions surrounding stem cells in planarians—small flatworms that are famous for being ...